Closed · W81XWH-22-PRCRP-CDA-SO · CFDA 12.420 · Discretionary
DoD Peer Reviewed Cancer, Career Development Award – Scholar Option
Federal grant opportunity posted by Dept. of the Army -- USAMRAA, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- October 20, 2022
- Close date
- 3
- Expected awards
The verdict
DoD Peer Reviewed Cancer, Career Development Award – Scholar Option is a closed discretionary listing from Dept. of the Army -- USAMRAA that offered Varies by applicant across 3 expected awards. Future funding cycles may be published under the same CFDA number.
- Varies
- award range
- Closed
- application status
- 3
- expected awards
- 12.420
- CFDA program
Opportunity snapshot. This Grants.gov announcement - DoD Peer Reviewed Cancer, Career Development Award – Scholar Option - is cataloged under number W81XWH-22-PRCRP-CDA-SO and tied to CFDA assistance listing 12.420, posted by Dept. of the Army -- USAMRAA. Grants.gov currently shows the opportunity as closed, first posted on August 4, 2022. The funding category is Discretionary, delivered as a grant.
Award economics. The award range on file is Varies by applicant. The agency has projected $3.8 million in total estimated funding for this announcement. It expects to issue 3 awards. If the agency funds the expected 3 awards from the $3.8 million estimated pool, the average award works out to roughly $1.3 million. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.
Deadline and action path. This opportunity closed on October 20, 2022. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.
Award Range
Varies by applicant
Close Date
October 20, 2022
Posted
August 4, 2022
Est. Total Funding
$3,830,000
Expected Awards
3
Instrument
Grant
Description
The PRCRP is seeking to advance cancer research through development of early-career investigators. This funding opportunity requests application for the Career Development Award – Scholar Option (also known as the Virtual Cancer Center Scholar Option. The Career Development Award – Fellow Option is not being offered at this time). Under this award mechanism, the early-career investigator is considered the Principal Investigator (PI), and the application should focus on the PI’s research and career development. Preliminary data are not required. However, logical reasoning and a sound scientific rationale for the proposed research must be demonstrated. This award supports impactful research projects with an emphasis on discovery. Scholar Option: Supports an independent, highly accomplished early-career investigator (referred to as a Scholar) to conduct impactful research under the guidance of an experienced cancer researcher (i.e., Career Guide). Scholars will commit to participate in the FY20 PRCRP Virtual Cancer Center (VCC) (CSVCC – Convergent Science Virtual Cancer Center). The unique, interactive VCC focuses on fostering the next generation of cancer researchers. This award provides intensive mentoring, national networking, and a peer group for junior faculty. Scholars are required to interact with the VCC Director, Deputy Director, and other Scholars in addition to their Career Guide. The intention of the Scholar Option is to support the highly accomplished investigator toward the goal of leadership in cancer. The critical components of the Career Development Award – Scholar Option: · Principal Investigator: The PI must be an early-career researcher or physician-scientist within 7 years after completion of their terminal degree by the time of the application deadline (excluding time spent in residency, clinical training, or on family medical leave). Time spent as a postdoctoral fellow is not excluded. Postdoctoral fellows are not eligible for this award mechanism. The PI’s record of accomplishments and the proposed research will be evaluated regarding their potential for contributing to at least one of the FY22 PRCRP Topic Areas in Section II.A.1. The Scholar must be in a tenure-track position or equivalent position. The Scholar must demonstrate significant accomplishments, including first-author publications, extramural funding, and show excellence in cancer research as supported by letters of recommendation. The Scholar must have independent laboratory space separate from the Career Guide’s laboratory or other mentor’s laboratory. The Scholar and Career Guide are required to attend a biennial multi-day VCC workshop and, in alternate years, a 1 day VCC workshop. For more information on the eligibility criteria for the Virtual Cancer Center Scholar Option, refer to Section II.C.1. · Career Guide: The Scholar must designate a Career Guide. The Career Guide must be an experienced cancer researcher, as demonstrated by a strong record of funding and publications. In addition, the Career Guide must demonstrate a commitment to advancing the PI’s career in cancer research. The Career Guide for applications submitted to the Career Development Award – Scholar Option (CDA-SO) must also be committed to fully participating in the VCC and potentially serving on the VCC’s Advisory Board as requested by VCC Leadership. · Career Development Plan: A career development plan is required and should be prepared with appropriate guidance from the Career Guide. The career development plan should include a clearly articulated strategy for acquiring the necessary skills, competence, further independence, and expertise to advance their career at the forefront of cancer research in at least one of the FY22 PRCRP Topic Areas. The Scholar must show career milestones and pathways toward achieving the milestones. The Scholar should demonstrate clear commitment to at least one of the FY22 PRCRP Topic Areas through a career development plan designed to enhance further networking and collaboration. The Scholar must also articulate interaction with the VCC. · Impact: The applicant must articulate the potential impact the proposed work will have on cancer research and/or patient care. Impactful research will accelerate the movement of promising ideas in cancer research into clinical applications. · Preliminary data are not required. Any preliminary data included in the application is subject to evaluation and review. Research proposed should be based on strong scientific reasoning and relevant literature.
Eligibility
Grants.gov lists this opportunity under eligibility category code 99. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org
Key Dates
Frequently Asked Questions
What is this grant opportunity?
Is this opportunity still open?
How much funding is available?
How do I apply?
More from Dept. of the Army -- USAMRAA
BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development Department of Defense
DOD Defense Health Agency (DHA) Research & Development FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research
Department of Defense HIV/AIDS Prevention Program
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
Related
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |